Sds Optic SA
WSE:SDS
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| PL |
S
|
Sds Optic SA
WSE:SDS
|
36.8m PLN |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
201.9B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.4B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
148B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
125B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
113.6B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.8B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.6B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.3B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.3B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD |
Loading...
|
Market Distribution
| Min | -535 500% |
| 30th Percentile | 18.1% |
| Median | 30.2% |
| 70th Percentile | 55.9% |
| Max | 807.1% |
Other Profitability Ratios
Sds Optic SA
Glance View
SDS Optic SA engages in the development of biochemistry, engineering, and fiber optic technologies solutions, which can be used in cancer diagnosis and treatment. The company is headquartered in Lublin, Woj. Lubelskie. The company went IPO on 2022-03-15. The Company’s primary research activity relates to the oncology sector. The Firm wishes to develop a method for early breast cancer diagnosis. The current method of diagnosis relies on biopsy and histopathology. The purpose of the tests is to identify cancer markers. The firm tries to implement InProbe method, which is faster and more accurate- the method should be able to provide results within 20 minutes. The firm is also engaged in research regarding different kinds of diseases such as fungal diseases. The firm cooperates with specialists from different fields such as biology, medicine, technology, and sciences related to medicine.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Sds Optic SA is 98.2%, which is above its 3-year median of -59 230.8%.
Over the last 3 years, Sds Optic SA’s Gross Margin has increased from -189.3% to 98.2%. During this period, it reached a low of -476 600% on Sep 30, 2024 and a high of 167.6% on Sep 30, 2023.
